Notably, bazedoxifene also suppressed tumor growth in mutant Apc‐driven intestinal tumors and in human colon cancer cell lines without reducing the excessive signaling output of the canonical WNT pathway that constitutes the underlying oncogenically activated driver pathway. This evidence concerns the gene APC and intestinal neoplasm.